Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology

Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology

Background: The t:slim X2™ insulin pump with Control-IQ™ technology, an advanced hybrid closed-loop system, became available in the United States in early 2020. Real-world outcomes with use of this system have not yet been comprehensively reported. Methods: Individuals with type 1 diabetes (T1D) (≥1...

Full description

Bibliographic Details
Main Authors: Constantin, A. (Author), Habif, S. (Author), Leas, S. (Author), Manning, M. (Author), McElwee Malloy, M. (Author), Müller, L. (Author), Pinsker, J.E (Author), Singh, H. (Author)
Format: Article
Language:English
Published: Mary Ann Liebert Inc. 2021
Subjects:
adolescent
Adolescent
adult
Adult
aged
antidiabetic agent
Article
Artificial pancreas
Automated insulin delivery
automation
Blood Glucose
blood glucose monitoring
Blood Glucose Self-Monitoring
controlled study
diabetes control
Diabetes Mellitus, Type 1
e-mail
female
Female
glucose
glucose blood level
glycemic control
Glycemic control
human
Humans
Hypoglycemic Agents
insulin
Insulin
insulin dependent diabetes mellitus
insulin infusion
Insulin Infusion Systems
insulin treatment
major clinical study
male
Male
middle aged
Middle Aged
Patient Reported Outcome Measures
patient satisfaction
patient-reported outcome
Patient-reported outcomes
priority journal
quality of life
Quality of Life
questionnaire
risk factor
sleep quality
technology
Technology
trust
Type 1 diabetes
United States
young adult
Young Adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items